Dr. Lan Luo, MD

Dr. Luo practices at Central Florida Heart Center in Ocala, Florida.

Dr. Luo's NPI, 1295938975, was assigned on June 8, 2007. Dr. Luo graduated from Shanghai Medical University in 1989. Dr. Luo holds Florida license ME106023.

Dr. Luo's primary practice is Central Florida Heart Center, at 3310 Sw 34th St, Ocala, FL 34474 in Marion County. The practice phone is (352) 873-0707.

Dr. Luo's primary practice is Central Florida Heart Center in Ocala, Florida. Dr. Luo is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Central Florida Heart Center. Dmand AI also links Dr. Luo to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luo practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Luo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Luo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Luo's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and chronic skin ulcer among the conditions Dr. Luo treats.

CMS data shows 17,085 Medicare services from Dr. Luo across 48 procedure codes in 2024, for 2,572 Medicare patients. Medicare paid $1,501,411 for them.

CMS counts 2,572 Medicare patients who saw Dr. Luo in 2024. The largest group is 75 to 84, with 1,073 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luo's median patient age at 74, with 53% women.

In 2024, Dr. Luo wrote 25,729 Medicare Part D claims for 3,113 patients. 79% of them were for generic drugs. CMS names the drug for 25,348 of them, across 105 drugs with 11 or more claims each, at $5,265,753 in total drug cost. In 2023, CMS named 21,940 claims across 100 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Luo for performance year 2024, reported as part of a group. Dr. Luo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Luo as offering telehealth. CMS counts 55 procedures of varicose vein removal by Dr. Luo, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 416 papers to Dr. Luo, published from 2010 to 2025. 2022 was the busiest year, with 46. The most frequent topics are China, Signal Transduction and Cell Proliferation. Dr. Luo has published most often in PLoS One. Dr. Luo's most frequent co-authors are Jae Kang, Un Jung Kang, MD and Pinky Agarwal, MD.

Dmand AI links Dr. Luo to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Luo that name 1 trial.

CMS Open Payments shows 747 general payments to Dr. Luo from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,427. It also lists 9 research payments totaling $36,540 from 2019 to 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Luo.

Dr. Luo graduated from Shanghai Medical University in 1989. Dr. Luo is a member of ACC.

Dr. Luo is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.